Results 101 to 110 of about 5,124 (246)
JCS/JHRS 2024 Guideline Focused Update on Management of Cardiac Arrhythmias
Journal of Arrhythmia, Volume 41, Issue 3, June 2025.
Yu‐ki Iwasaki +37 more
wiley +1 more source
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 44, Issue 5, Page 394-408, May 2024.Abstract Previous meta‐analyses assessed andexanet alfa (AA) or prothrombin complex concentrate (PCC) products for the treatment of Factor Xa inhibitor (FXaI)‐associated major bleeding. However, they did not include recent studies or assess the impact of the risk of bias.
C. Michael White +8 more
wiley +1 more source
Viewpoint Stroke prevention in recent guidelines for the management of patients with atrial fibrillation: An appraisal. [PDF]
, 2017 Formal guidelines play an important role in disseminating the best available evidence knowledge and are expected to provide simple and practical recommendations for the most optimal management of patients with various conditions.
Camm, AJ +4 more
core +3 more sources
Ibrain, Volume 10, Issue 1, Page 59-68, Spring 2024.The accompanying paper presents a comprehensive review of case studies focusing on the impact of intravenous thrombolysis and mechanical thrombectomy within a 4.5‐h time frame on hemiplegia in patients with acute ischemic strokes. The study evaluates the effectiveness of these interventions in improving neurological symptoms and functional outcomes. It
Karen Adriana Carrillo Navarrete +1 more
wiley +1 more source
The toxicokinetic profile of Dex40-GTMAC3 : a novel polysaccharide candidate for reversal of unfractionated heparin [PDF]
, 2016 Though protamine sulfate is the only approved antidote of unfractionated heparin (UFH), yet may produce life threatening side effects such as systemic hypotension, catastrophic pulmonary vasoconstriction or allergic reactions.
Błażejczyk, Agnieszka +10 more
core +2 more sources
International Journal of Laboratory Hematology, Volume 46, Issue 1, Page 120-127, February 2024.Abstract Introduction The knowledge of dabigatran levels is helpful for decision‐making in specific situations such as urgent surgery or when the question of reversal arises (uncontrolled bleeding, eligibility for thrombolysis). However, a limited number of observational studies are available regarding comparisons between quantification methods.
Ambre de Fautereau‐Vassel +8 more
wiley +1 more source
Российский кардиологический журнал, 2020 Aim. To study the characteristics of direct oral anticoagulant-related bleeding in patients with heart failure in combination with chronic obstructive pulmonary disease (COPD) and atrial fibrillation.
L. A. Shpagina +10 more
doaj +1 more source
Intravenous Thrombolysis after Reversal of Dabigatran by Idarucizumab: A Case Report
Case Reports in Neurology, 2016 We describe a 75-year-old female patient with nonvalvular atrial fibrillation who presented with acute ischemic stroke during treatment with dabigatran 2 × 110 mg per day.
Waldemar Kafke +2 more
doaj +1 more source
Fibrilación auricular en los servicios de urgencias hospitalarias [PDF]
, 2016 La fibrilación auricular (FA) es la arritmia cardíaca sostenida más frecuente en la población. Es una enfermedad grave y es un factor predictivo independiente de mortalidad, asociando un riesgo de ictus 5 veces superior a la población general.
García Palacios, José David
core
Perspectivas clínicas del manejo de la hemorragia en el paciente tratado con anticoagulante oral: estudio DECOVER [PDF]
, 2018 Objetivo. Evaluar el grado de acuerdo entre hematólogos y urgenciólogos respecto a las mejores prácticas para el manejo de hemorragias y la reversión de la anticoagulación oral. Método.
Camats, Míriam +12 more
core